Latest from Biotechnology

From virtual heart to virtual human

Innate forced to trim research after cash shortfall

Bio-tech firm sees chance for fruitful float

Hamilton-based bio-technology company BioVittoria is hoping investors will see a sweet opportunity in its sharemarket float.

<i>Anthony Doesburg:</i> Green energy in the doldrums

BioVittoria seeks capital

Robber takes on technology

Wool Equities directors resign en masse

Genome sequencing gets cheaper by the day

Partial bid for Rubicon scrip

Symansis wins emerging company award

Scientists a step closer to creating artificial life

<i>Bronwyn Dilley:</i> Bioeconomy seen as key to future success

Biotech still waiting to be paid

Strict rules hedge 10-year GE onion trial

Bringing old woollies back to life

Core biotech companies triple in three years